Protein SPDEF in Prostate Cancer Cells Don’t Survive Possible Metastasis Sites

July 7, 2012 by  
Filed under Prostate Cancer News

Recently, researchers at the University of Colorado Cancer Center study published the finding of their prostate cancer research in the Journal of Biological Chemistry.

This study shows that loss of the protein SPDEF allows prostate cancer cells to gain foothold at possible sites of metastasis. The SPDEF protein is usually found in prostate cancer cells but if they are lost through any means, then prostate cancer’s spread to other tissues would really stimulated.

The findings of this research were posted online at the Science Daily website on July 6, 2012. Here is the extract on this new prostate cancer study:

Prostate cancer doesn’t kill in the prostate — it’s the disease’s metastasis to other tissues that can be fatal. A University of Colorado Cancer Center study published this week in the Journal of Biological Chemistry shows that prostate cancer cells containing the protein SPDEF continue to grow at the same pace as their SPDEF- cousins, but that these SPDEF+ cells are unable to survive at possible sites of metastasis.

“It’s as if these cancer cells with SPDEF can’t chew into distant tissue and so are unable to make new homes,” says Hari Koul, PhD, investigator at the CU Cancer Center and director of urology research at the University of Colorado School of Medicine, the study’s senior author.

Koul and his group discovered the homesteading power of cancer cells that have lost SPDEF by introducing a gene into cells that makes them glow in the presence of a dye, and then introducing them into the bloodstream of animal models. Cells without SPDEF traveled through the blood and successfully attached to tissue, surviving and so fluorescing many weeks later when dye was introduced. However, cells with SPDEF flowed through the blood but were unable to successfully establish new colonies and so soon died out.

In fact, the protein SPDEF doesn’t act directly to allow cells to attach at possible metastasis sites, but is a transcription factor that controls the production (or lack thereof) of two other proteins MMP9 and MMP13. These two downstream proteins work to break down tissue, like a dissolving agent — they are the cleaning crew that clears space for new and different growth, and in the case of prostate cancer metastasis they chip the tissue footholds that cancer cells need to create micrometastases.

“Given that MMP9 and perhaps MMP13 are also involved in metastasis of several other cancers including lung, ovarian, breast and colon to name a few, our findings could potentially have far-reaching consequences outside prostate cancer,” adds Koul

The group’s continuing work points in two directions.

“First, we hope that the presence of SPDEF could help doctors recognize prostate cancers that don’t require treatment.” If future studies confirm the group’s initial findings, the presence of SPDEF could predict prostate cancers that are unable to metastasize and so unable to kill. These cancers could be left to run their course without the use of treatments that sometimes carry difficult side effects.

“And second,” Koul says, “we hope to regulate expression of this protein to remove prostate cancers’ ability to metastasize.”

Koul points to small molecules, gene therapy or nanodelivery as possible mechanisms for introducing SPDEF into cells that lack the protein.

“With this discovery we have opened a hopeful door into a future in which prostate and potentially other cancers are unable to metastasize,” Koul says. Source

Conslusively, there is no doubt that this study is quite interesting and critical at this present time when there are controversies generated by recommendations of the US Preventive Services Task Force.

More, studies on this research may confirm whether to treat cancer of the prostate that has not being a threat. More so, further investigations can as well help in determining a new course for treating and managing this disease.

We hope that the next direction the above research will take would really be useful helping clinicians in providing potent treatments for prostate cancer.

Below Are Other Related Articles Among 1,000+ Prostate Cancer Articles On
This HUGE 4+ Year Old Prostate Cancer Victory Authority Website:

(95% of these 1,000+ Prostate Cancer Articles on this website
are written by our Expert In -house Writers, after lots of research.
The remaining 5% are news articles and videos from relevant sources!)


  1. Bone Metastasis of Prostate Cancer – Important Tips That Many Don’t Know
  2. Scientists Identify a Protein that May Cause Aggressive Prostate Cancer
  3. Prostrate Cancer Metastasis – Scalp Metastasis of Prostate Cancer
  4. Cancer De La Prostate Et Ses Metastasis – Metastasis of Prostate Cancer
  5. GEDI Chip May Help Detect Prostate Cancer Cells in the Bloodstream
  6. Metastasis Prostate Cancer
  7. Advanced Prostate Cancer and Bone Metastasis
  8. Bone Metastasis Prostate Cancer – Why You Should Be Worried
  9. Bone Metastasis of Prostate Cancer – Symptoms and Treatment
  10. Whats Prostate Cancer Staging – The Different Stages That Many People Don’t Know About
  11. Prostate Cancer D Bone Metastasis Treatment
  12. Bone Metastasis Prostate Cancer – Symptoms And Treatments
  13. What Organs Affect Prostate Cancer – Learn More about The Metastasis of the disease
  14. Prostrate Cancer Symptoms – DON’T Wait Until It’s Too Late
  15. Metastasis Prostate Cancer

Speak Your Mind

Tell us what you're thinking... !

s